Shenzhen Salubris Pharmaceuticals Co Ltd (002294) - Total Liabilities

Latest as of September 2025: CN¥2.05 Billion CNY ≈ $300.34 Million USD

Based on the latest financial reports, Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has total liabilities worth CN¥2.05 Billion CNY (≈ $300.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Shenzhen Salubris Pharmaceuticals Co Ltd to track the company's year-over-year net asset growth rate.

Shenzhen Salubris Pharmaceuticals Co Ltd - Total Liabilities Trend (2006–2024)

This chart illustrates how Shenzhen Salubris Pharmaceuticals Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Shenzhen Salubris Pharmaceuticals Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Shenzhen Salubris Pharmaceuticals Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shenzhen Salubris Pharmaceuticals Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Black Hills Corporation NYSE:BKH	USA	$6.79 Billion
YANGTZE OPT.FIB.AND CAB.H F:1YO	Germany	€16.63 Billion
Gerdau SA ADR NYSE:GGB	USA	$28.08 Billion
Bachem Holding AG SW:BANB	Switzerland	CHF650.41 Million
3SBio Inc F:83B	Germany	€5.81 Billion
GREEK O.FOOTB. ADR 1/2 F:GF8A	Germany	€1.75 Billion
Shenghe Resources Holding Co Ltd SHG:600392	China	CN¥8.06 Billion
ICL Israel Chemicals Ltd TA:ICL	Israel	ILA6.17 Billion

Liability Composition Analysis (2006–2024)

This chart breaks down Shenzhen Salubris Pharmaceuticals Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002294 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Salubris Pharmaceuticals Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

The table below shows the annual total liabilities of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.71 Billion ≈ $250.71 Million	+27.74%
2023-12-31	CN¥1.34 Billion ≈ $196.27 Million	-24.59%
2022-12-31	CN¥1.78 Billion ≈ $260.26 Million	+48.43%
2021-12-31	CN¥1.20 Billion ≈ $175.34 Million	-9.69%
2020-12-31	CN¥1.33 Billion ≈ $194.16 Million	+24.36%
2019-12-31	CN¥1.07 Billion ≈ $156.12 Million	+3.22%
2018-12-31	CN¥1.03 Billion ≈ $151.25 Million	+46.43%
2017-12-31	CN¥705.86 Million ≈ $103.29 Million	-34.28%
2016-12-31	CN¥1.07 Billion ≈ $157.17 Million	+55.38%
2015-12-31	CN¥691.25 Million ≈ $101.15 Million	-16.51%
2014-12-31	CN¥827.95 Million ≈ $121.16 Million	+62.87%
2013-12-31	CN¥508.36 Million ≈ $74.39 Million	+35.92%
2012-12-31	CN¥374.02 Million ≈ $54.73 Million	+20.45%
2011-12-31	CN¥310.52 Million ≈ $45.44 Million	+0.33%
2010-12-31	CN¥309.50 Million ≈ $45.29 Million	+108.30%
2009-12-31	CN¥148.59 Million ≈ $21.74 Million	+1.98%
2008-12-31	CN¥145.70 Million ≈ $21.32 Million	+32.48%
2007-12-31	CN¥109.98 Million ≈ $16.09 Million	+110.74%
2006-12-31	CN¥52.19 Million ≈ $7.64 Million	--

About Shenzhen Salubris Pharmaceuticals Co Ltd

SHE:002294 China Drug Manufacturers - Specialty & Generic

Market Cap

$5.42 Billion

CN¥37.01 Billion CNY

Market Cap Rank

#3368 Global

#446 in China

Share Price

CN¥33.20

Change (1 day)

-0.24%

52-Week Range

CN¥30.15 - CN¥68.30

All Time High

CN¥68.30